Effectiveness Test of Epigallocatechin Gallate Cream Formula in Acne Vulgaris Therapy
Sciences of Pharmacy · 15.05.2026 · 5 (2) · 169-175
DOI: 10.58920/sciphar0502542 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sciences of Pharmacy, online erschienen am 15.05.2026. Verfasst von Naniek Widyaningrum und 4 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acne vulgaris is a chronic inflammatory disease of the pilosebaceous follicles that affects more than 80% of adolescents and young adults. Conventional therapies such as antibiotics and topical retinoids have limitations in the form of resistance and irritation. Epigallocatechin gallate (EGCG) from green tea leaves (Camellia sinensis L.) has antibacterial, anti-inflammatory, and antioxidant activities that make it a safe natural anti-acne candidate. The aim of this study was to assess the clinical efficacy and safety of topical EGCG cream on the improvement of inflammatory and non-inflammatory acne lesions. A pre-post clinical trial was conducted on ten participants aged 17–50 years with active acne. Respondents applied 6% EGCG cream twice daily for six months. The number of lesions (papules, pustules, and blackheads) was evaluated monthly and analyzed using a paired t-test (p
Zitieren
APA
Widyaningrum, N., Dhea, A., Rofi, A., Arief, T., & Timur, W. (2026). Effectiveness Test of Epigallocatechin Gallate Cream Formula in Acne Vulgaris Therapy. Sciences of Pharmacy, 5(2), 169-175. https://doi.org/10.58920/sciphar0502542
Vancouver
Widyaningrum N, Dhea A, Rofi A, Arief T, Timur W. Effectiveness Test of Epigallocatechin Gallate Cream Formula in Acne Vulgaris Therapy. Sciences of Pharmacy. 2026;5(2):169-175. doi:10.58920/sciphar0502542
BibTeX
@article{Widyaningrum2026,
author = {Widyaningrum, Naniek and Dhea, Alda and Rofi, Alina and Arief, Thendi and Timur, Willi},
title = {Effectiveness Test of Epigallocatechin Gallate Cream Formula in Acne Vulgaris Therapy},
journal = {Sciences of Pharmacy},
year = {2026},
volume = {5},
number = {2},
pages = {169--175},
doi = {10.58920/sciphar0502542}
}
EUVIMED